Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft.
Learn more about your ad choices. Visit megaphone.fm/adchoices

46: Biotech's Big Idea

The Readback explores why only a few of our most hyped companies and ideas end up meeting their promise. The lessons learned hold value not just for investors, but for everyone trying to find the next big thing.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Autonomous cars have reached a fork in the road. The path forward could make or break the technology.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Road Ahead

The government has taken a hands-free approach to self-driving. Why that's stalling progress.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Time to Take the Wheel

As self-driving momentum builds, a chorus of voices says we shouldn't be doing this at all.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Tapping the Brakes

New autonomous technologies have people pushing vehicles well beyond their limits. Inside one experiment to see just how far our cars will go.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Backseat Driver

Even as car makers roll out new self-driving features, consumers remain skeptical. Why they're tapping the brakes on change.

Learn more about your ad choices. Visit megaphone.fm/adchoices

46: Biotech's Big Idea

Download our free app to listen on your phone